通过PHF5A进行剪接控制对于黑色素瘤细胞存活至关重要
Tina Meißgeier1, Melanie Kappelmann-Fenzl1,2, Sebastian Staebler1
1Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Cell proliferation
|August 30, 2024
概括
PHD指蛋白5A (PHF5A) 通过导致拼接缺陷驱动黑色素瘤恶性病变. 降低PHF5A的调节会增加细胞亡,为这种侵袭性皮肤癌提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 替代拼接异常是癌症发展的关键.
- 恶性黑色素瘤是一种致命的皮肤癌,与高PHF5A表达率的患者的生存率差有关.
研究的目的:
- 为了研究PHF5A剪接因子在黑色素瘤中的作用.
- 探索PHF5A对拼接,亡以及其作为治疗点的潜力的影响.
主要方法:
- 在黑色素瘤细胞系中,siRNA介导的PHF5A的下调.
- 对瘤相关基因的拼接缺陷的分析.
- 研究亡途径,包括Fas和未折叠蛋白质反应 (UPR).
主要成果:
- 低调PHF5A导致黑色素瘤细胞出现显著的拼接缺陷.
- 通过Fas和UPR通路诱导PHF5A诱导的亡.
- 这些影响是针对瘤细胞的特异性,而不是在纤维细胞中观察到的.
结论:
- PHF5A 是黑色素瘤恶性病的关键驱动因素.
- 由PHF5A调节的已识别的拼接网络为黑色素瘤治疗提供了潜在的治疗点.
相关概念视频
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


